Aaron Richman
Internal Medicine · Cortlandt Manor, NYNPI 1093714156
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 321 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $2,078 and has fallen 97.0% since, to $63 in 2022.
Across 321 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$905
- AstraZeneca$611
- GSK$524
- Novo Nordisk$419
- Boehringer Ingelheim$399
- Lilly USA, LLC$322
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,123100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $905 |
| AstraZeneca | 42 | $611 |
| GSK | 28 | $524 |
| Novo Nordisk | 29 | $419 |
| Boehringer Ingelheim | 20 | $399 |
| Lilly USA, LLC | 24 | $322 |
| Merck | 23 | $317 |
| Amarin Pharma, Inc. | 15 | $259 |
| Novartis | 15 | $185 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $152 |
| Johnson & Johnson | 6 | $119 |
| Daiichi Sankyo Inc. | 6 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| Teva Pharmaceuticals USA, Inc. | 5 | $79 |
| E.r. Squibb & Sons, L.L.C. | 5 | $78 |
| Arbor Pharmaceuticals, Inc. | 4 | $68 |
| Esperion Therapeutics, Inc. | 3 | $64 |
| IBSA Pharma Inc. | 3 | $53 |
| Strongbridge US Inc. | 3 | $44 |
| Kowa Pharmaceuticals America, Inc. | 3 | $41 |
| Astellas Pharma US Inc | 2 | $34 |
| Genentech USA, Inc. | 2 | $34 |
| Abbott | 2 | $30 |
| Sanofi Pasteur Inc. | 2 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $20 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Mannkind Corporation | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Circassia Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Medtronic | 1 | $13 |
| Metuchen Pharmaceuticals | 1 | $12 |
How this compares
$5,143 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Cortlandt Manor
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.